Luteolin Inhibits Breast Cancer Development and Progression In Vitro and In Vivo by Suppressing Notch Signaling and Regulating MiRNAs

被引:115
|
作者
Sun, Da-Wei [1 ]
Zhang, He-Da [2 ]
Mao, Ling [3 ]
Mao, Chang-Fei [4 ]
Chen, Wei [2 ]
Cui, Meng [5 ]
Ma, Rong [6 ]
Cao, Hai-Xia [6 ]
Jing, Chang-Weng [6 ]
Wang, Zhuo [6 ]
Wu, Jian-Zhong [6 ]
Tang, Jin-Hai [1 ,7 ]
机构
[1] Nanjing Univ Chinese Med, Nanjing 210023, Jiangsu, Peoples R China
[2] Xuzhou Med Coll, Grad Sch, Xuzhou, Peoples R China
[3] Xuzhou Med Coll, Huaian Peoples Hosp 2, Dept Gen Surg, Huaian, Peoples R China
[4] Nanjing Med Univ, Clin Coll 4, Nanjing, Jiangsu, Peoples R China
[5] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China
[6] Jiangsu Canc Hosp, Res Ctr Clin Oncol, Nanjing, Jiangsu, Peoples R China
[7] Jiangsu Canc Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Luteolin; Notch signaling; miRNA; Breast cancer; DOWN-REGULATION; HUMAN HEPATOMA; GROWTH-FACTOR; EXPRESSION; CELLS; INVASION; PATHWAY; IDENTIFICATION; MICRORNA-155; CONTRIBUTES;
D O I
10.1159/000438535
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background/Aims: This study aims to investigate the effect of Luteolin on breast cancer in vitro and in vivo and the interaction between miRNAs and Notch signaling after Luteolin intervention, and illustrates the possible underlying mechanism and regulation loop. Methods: Cell growth/survival assays and cell cycle analyses were performed to evaluate cell survival in vitro. Scratch tests, cell invasion assays and tube formation assays were carried out to analyze cell viability and identify the impact of Luteolin on angiogenesis. Critical components in the Notch pathway including proteins and mRNAs were detected by Western blotting analyses, ELISA assays and real-time reverse transcription-polymerase chain reaction. Matrix metalloproteinases activity was evaluated by gelatin zymography analyses. MiRNAs were analyzed by miRNA expression assays. After MDA-MB-231 cells were separately transfected with Notch-1 siRNA/cDNA and miRNA mimics, the above assays were also carried out to examine potential tumor cell changes. Xenograft models were applied to evaluate the treatment potency of Luteolin in breast cancer. Results: Luteolin significantly inhibited breast cancer cell survival, cell cycle, tube formation and the expression of Notch signaling-related proteins and mRNAs, and regulated miRNAs. After introducing Notch-1 siRNA and miRNA mimics, MDA-MB-231 cells presented with changes in miRNA levels, reduced Notch signaling-related proteins, and decreased tumor survival, invasion and angiogenesis. Conclusion: Luteolin inhibits Notch signaling by regulating miRNAs. However, the effect of miRNAs on the Notch pathway could be either Luteolin-dependent or Luteolin-independent. Furthermore, Notch-1 alteration may inversely change miRNAs levels. Our data demonstrates that Luteolin, miRNAs and the Notch pathway are critical in breast cancer development and prognosis. Copyright (C) 2015 S. Karger AG, Basel
引用
收藏
页码:1693 / 1711
页数:19
相关论文
共 50 条
  • [1] Daurisoline Inhibits Progression of Triple-Negative Breast Cancer by Regulating the γ-Secretase/Notch Axis
    Zhan, Xiangyi
    Chen, Xiaoyong
    Feng, Mei
    Yao, Kuo
    Yang, Kefan
    Jia, Hui
    BIOMOLECULES & THERAPEUTICS, 2025, 33 (02) : 331 - 343
  • [2] Suppressing NRIP1 inhibits growth of breast cancer cells in vitro and in vivo
    Aziz, Moammir H.
    Chen, Xundi
    Zhang, Qi
    DeFrain, Chad
    Osland, Jared
    Luo, Yizhou
    Shi, Xin
    Yuan, Rong
    ONCOTARGET, 2015, 6 (37) : 39714 - 39724
  • [3] CMTM7 inhibits breast cancer progression by regulating Wnt/β-catenin signaling
    Zhao-Hui Chen
    Yao Tian
    Guang-Lei Zhou
    Hao-Ran Yue
    Xue-Jie Zhou
    Hai-Yan Ma
    Jie Ge
    Xin Wang
    Xu-Chen Cao
    Yue Yu
    Breast Cancer Research, 25
  • [4] CMTM7 inhibits breast cancer progression by regulating Wnt/β-catenin signaling
    Chen, Zhao-Hui
    Tian, Yao
    Zhou, Guang-Lei
    Yue, Hao-Ran
    Zhou, Xue-Jie
    Ma, Hai-Yan
    Ge, Jie
    Wang, Xin
    Cao, Xu-Chen
    Yu, Yue
    BREAST CANCER RESEARCH, 2023, 25 (01)
  • [5] MiR-1294 inhibits the progression of breast cancer via regulating ERK signaling
    Chen, Kejie
    Xiao, Xiapeng
    Xu, Zhiping
    BULLETIN DU CANCER, 2022, 109 (10) : 999 - 1006
  • [6] Paeoniflorin inhibits proliferation and invasion of breast cancer cells through suppressing Notch-1 signaling pathway
    Zhang, Qiang
    Yuan, Yonghui
    Cui, Jianchun
    Xiao, Tingting
    Jiang, Daqing
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 78 : 197 - 203
  • [7] TFPI inhibits breast cancer progression by suppressing ERK/p38 MAPK signaling pathway
    Mengying Xing
    Ying Yang
    Jiaxue Huang
    Yaqun Fang
    Yucui Jin
    Lingyun Li
    Xiang Chen
    Xiaoxia Zhu
    Changyan Ma
    Genes & Genomics, 2022, 44 : 801 - 812
  • [8] TFPI inhibits breast cancer progression by suppressing ERK/p38 MAPK signaling pathway
    Xing, Mengying
    Yang, Ying
    Huang, Jiaxue
    Fang, Yaqun
    Jin, Yucui
    Li, Lingyun
    Chen, Xiang
    Zhu, Xiaoxia
    Ma, Changyan
    GENES & GENOMICS, 2022, 44 (07) : 801 - 812
  • [9] Luteolin inhibits melanoma growth in vitro and in vivo via regulating ECM and oncogenic pathways but not ROS
    Schomberg, John
    Wang, Zi
    Farhat, Ahmed
    Guo, Katherine L.
    Xie, Jun
    Zhou, Zhidong
    Liu, Jing
    Kovacs, Bruce
    Liu-Smith, Feng
    BIOCHEMICAL PHARMACOLOGY, 2020, 177
  • [10] Luteolin Inhibits Melanoma Growth in Vitro and in Vivo via Regulating ECM and Immune Responses but not ROS
    Liu-Smith, Feng
    Schomberg, John
    Wang, Zi
    Liu, Jing
    Farhat, Ahmed
    Guo, Katherine
    Kovacs, Bruce
    Meyskens, Frank
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 145 : S71 - S71